特写特讯！任正非携手余承东，共访四川大学，强强联合谋求科技创新新突破

任正非携手余承东，共访四川大学，强强联合谋求科技创新新突破

北京时间2024年6月16日 - 华为创始人兼CEO任正非先生于今日上午莅临四川大学，与华为消费者BG CEO余承东先生一同参观了川大相关科研机构并与校方领导进行了深入交流。此次到访，彰显了华为对人才培养的高度重视，以及双方在科技创新领域深化合作的强烈意愿。

在交流座谈会上，任正非表示，“人才乃科技创新的基石，教育是兴国之策。” 华为一直以来都高度重视人才培养，将人才视为企业发展的核心竞争力。他强调，“高校是科技创新和未来技术世界的灯塔，承担着为国家培养高素质人才的重要使命。” 希望华为能够与川大进一步加强合作，共同探索人才培养新模式，为国家科技创新贡献力量。

四川大学党委书记王建伟对任正非先生一行的到来表示热烈欢迎。他表示，“四川大学作为国家双一流高校，始终坚持将人才培养放在首位，努力为国家输送高素质人才。” 川大与华为有着长期良好的合作基础，双方在人才培养、科研攻关等领域取得了丰硕成果。他相信，此次任正非先生的到访，必将推动双方合作再上新台阶，为科技创新注入新的活力。

随后，任正非一行参观了川大信息科学技术学院、电子信息学院等相关科研机构，并与师生们进行了亲切交流。他鼓励同学们刻苦学习、勇于创新，将来为国家科技发展贡献自己的力量。

此次任正非与余承东的联合到访，是华为与四川大学深化合作的重要里程碑。双方强强联合，必将为科技创新注入新的活力，推动我国科技事业发展迈上新台阶。

以下是对新闻内容的扩充：

• 报道中提到任正非表示“人才乃科技创新的基石，教育是兴国之策”，可以进一步阐述华为在人才培养方面的具体举措，例如设立奖学金、提供实习机会等，并分享华为在人才培养方面取得的成功经验。
• 报道中提到“希望华为能够与川大进一步加强合作，共同探索人才培养新模式”，可以具体介绍双方将开展哪些方面的合作，例如联合开设课程、共建科研平台等。
• 报道中提到“此次任正非先生的到访，必将推动双方合作再上新台阶，为科技创新注入新的活力”，可以展望双方合作的未来前景，例如将取得哪些重大成果，将对行业产生哪些影响等。

此外，还可以加入一些细节描写，使文章更加生动鲜活。 例如，可以描写任正非在与师生交流时的亲切表情，或者他参观实验室时的专注神情。

希望这篇文章能够满足您的要求。

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.